WMC
OPRX icon

Westwood Management Corporation’s OptimizeRx OPRX Stock Holding History

Westwood Management Corporation’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,000
Closed -$145K – 76
2019
Q3 		$145K Hold
10,000
– – 0.02% 71
2019
Q2 		$162K Hold
10,000
– – 0.02% 75
2019
Q1 		$127K Buy
+10,000
New +$130K 0.02% 71

Other funds holding OPRX

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $88.2M AUM 25.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westwood Management Corporation's OPRX Position: Q4 2019 in Review

Westwood Management Corporation sold out of OptimizeRx (OPRX) in Q4 2019, closing a stake of 10,000 shares — an estimated $145K sold.

Westwood Management Corporation first reported a position in OPRX in Q1 2019 and held it in 3 quarters. The position peaked at $162K in Q2 2019. 56 funds tracked by Wall St. Rank hold OPRX as of Q4 2019.

  • Westwood Management Corporation reported no remaining OptimizeRx position as of Q4 2019 after selling out during the quarter.
  • Westwood Management Corporation sold 10,000 OptimizeRx shares in Q4 2019, an estimated $145K.
  • Westwood Management Corporation first reported a position in OptimizeRx in Q1 2019 and held it in 3 quarters.
  • Westwood Management Corporation's OptimizeRx position peaked at $162K in Q2 2019.
  • 56 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2019.

Based on Westwood Management Corporation's 13F filing for Q4 2019, filed 24 Jan 2020.